oral HDV-Insulin (Oral HDV-I) / Diasome - LARVOL DELTA

A Single-Blind, Placebo-Controlled, Dose-Ranging Trial of Oral HDV-Insulin in Patients With Type 2 Diabetes Mellitus (clinicaltrials.gov) - P=N/A; N=6; Completed; Sponsor: Diasome Pharmaceuticals; N=20 ➔ 6

Clinical • Enrollment change • Diabetes • Metabolic Disorders • Type 1 Diabetes Mellitus • Type 2 Diabetes Mellitus

Study of Two Doses of Oral HDV-Insulin and Placebo With Background Metformin Treatment in Patients With Type 2 Diabetes Mellitus (clinicaltrials.gov) - P2/3; N=239; Completed; Sponsor: Diasome Pharmaceuticals; Active, not recruiting ➔ Completed

Clinical • Trial completion • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus